ArticleAnnals of medicine and surgery (2012)2025
FDA approval of crovalimab: a milestone in paroxysmal nocturnal hemoglobinuria treatment.
Diya Anwar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it